Frontlight ResearchEarly access
Long COVID and ME/CFS trials in Japan
1 trial · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- Where
- Kodaira
- Age
- 18 years to 65 years
- People
- 30
- Run by
- National Center of Neurology and Psychiatry, Japan
See details and how to joinNCT06952413